Traditional facility building processes burn through millions of capital dollars and years of potential manufacturing time, said Clark H. Byrum, Jr., President and CEO of Biologics Modular. The current business model for drug manufacturing companies is changing, and as we see more offsite research and development, there is a growing need for affordable quality facilities. The new initiative is intended to allow research park companies to innovate more quickly without draining their capital.
Craig Atcheson, President of MEI Healthcare Capital, stated MEIs years of experience in the healthcare finance industry have enabled us to structure and implement these kinds of creative financing programs, and we are pleased to provide this resource for Biologics customers.
This program was created to meet the specific capital structure needs of Biologics Modulars current and potential clients. This new arrangement will allow all innovation models to have an equal opportunity to access CGMP compliant manufacturing facilities at an affordable price.
About Biologics Modular:
Headquartered in Brownsburg, IN, Biologics Modular is a manufacturer of mobile and modular facilities for the CGMP industries. Biologics Modular also possesses the support services to navigate through the FDA regulatory process.
About MEI:
The MEI Healthcare Group, LLC, parent company of MEI Healthcare Capital, LLC, is headquartered in Coral Springs, FL, and is a healthcare strategy firm working with physician groups, hospitals, manufacturers and medical centers to provide turnkey healthcare solutions project feasibility studies, healthcare analytics and consulting services, capital equipment acquisitions, project financing and marketing and branding strategies.
